Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2. (scientific article published on May 2008)

scientific article published on May 2008

Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2. is …

scholarly article

External links are

P356	DOI	10.1002/JCB.21659
P698	PubMed publication ID	18172853

P2093

author name string

Kazumichi Furuyama

Norio Komatsu

Keiya Ozawa

Tadashi Nagai

Ken Ohmine

Takuji Miyoshi

Takahito Kondo

Satoru Kikuchi

Makiko Nakamura

P2860

cites work

Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site

Q24647985

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

Q29619570

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

Q40512568

5-Aminolevulinate synthase expression and hemoglobin synthesis in a human myelogenous leukemia cell line

Q41122512

P433

issue

P921

main subject

imatinib

Q177094

P304

page(s)

680-691

P577

publication date

2008-05-01

P1433

published in

Journal of Cellular Biochemistry

Q6294917

P1476

title

Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2.

P478

volume

104

Reverse relations

cites work (P2860)

Q35991845	A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.
Q35390252	Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization
Q36956185	Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione
Q39737530	Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism
Q38869922	Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
Q91900245	Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
Q39113045	Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.